Review Article
Lipid-Based Drug Delivery Systems
Table 4
Some of the commercially available lipid-based formulations.
| Molecules/trade name | Indication | Dose | Type of formulation | Lipid excipients and surfactants |
| Calcitriol/Rocaltrol | Calcium regulator | Adult: 0.25–0.5 g q.d. | Soft gelatin capsule | Fractionated triglyceride of coconut oil | Cyclosporin/Nerol | Immunosuppressant | 2–10 mg/kg/day b.i.d. | Soft gelatin capsule | Cremophor RH 40 | Tretinoin/Vesanoid | Antineoplastic |
45 mg/m2 subdivided | Soft gelatin capsule | Bees wax, hydrogenated soybean oil | Valporic acid/Depakene | Antiepileptic | 10–60 mg/kg/day | Soft gelatin capsule | Corn oil | Fenofibrate/Fenogal | Antihyperlipoproteinemic | 200 mg q.d | Hard gelatin capsule | Gelucire | Testosterone/Restandol | Hormone replacement therapy | 40–160 mg q.d. | Soft gelatin capsule | Oleic acid |
|
|